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Introduction: Drug safety became very important topic in the second half of 20th century, 
even beyond pharmacy. It relates to increasing impact on testing of drugs before launch 
onto the market, but also following monitoring, so the benefit and risk ratio of drug can be 
determined. Pharmacovigilance takes care of monitoring of drug use risk. Zolpidem is active 
substance from class hypnotics and it is used for short-term treatment of insomnia. Most 
professionals recommend zolpidem as first line treatment of acute insomnia. That is why it 
can be considered as one of the most important hypnotic drugs. 
Objectives: The aim of this diploma thesis is to analyze spontaneous reports for adverse drug 
reaction for zolpidem from years 2004 to 2017. The thesis focus on reports from the Czech 
republic but also from the whole world. The information in SPC of medicinal products 
containing zolpidem which were distributed from 2004 to 2017 are compared. 
Methods: Following data from years 2004 to 2017 were used: 1) List of spontaneous reports 
for adverse reaction from the Czech republic (source: SÚKL) 2) List of spontaneous reports 
for adverse reaction from the whole world (source: EMA) 3) List of medicinal products 
distribution in the Czech republic (source: SÚKL) 4) SPC of medicinal products containing 
zolpidem distributed in the Czech republic. 
Results and conclusion: Use of zolpidem in the Czech republic was increasing from year 2004 
to 2017. 53, 6 % of DDD of zolpidem were distributed in big 100 tablet packages in 2017, 
which leads to suspicion that the big packages can be misused. Number of report for 
zolpidem was increasing. The reason is increase of use of zolpidem and general increase of 
all reports. There was no other suspicious orinteracting drug reportedalong with zolpidem in 
68 % reports. 89 % of reports were serious. More than half of patients from reports were 
women. Patients from report were from all ages categories. Almost half of reports were 
from doctors, almost quarter from pharmacists, the rest were from patients and other 
medical staff members. Number of reports for zolpidem in the world also increase. Same 
categories of adverse drug reactions are reported in both world and the Czech republic. 
 
